1. Market Research
  2. > Pathology
Customer Support

Talk to Ahmad

+1 718 618 4302

Top Countries

About 200 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Lymphoma Treatment Drugs Markets in China

  • $ 4000
  • October 2019
  • 206 pages

Developing Lymphoma Treatment Drugs is very important in curing Lymphoma illness.

  • Lymphoma
  • Pharmaceutical
  • China
  • Shenzhen Main Luck Pharmaceuticals Inc.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.

Lymphoma Treatment Drugs Companies in China

  • $ 1800
  • October 2019
  • 71 pages

Developing Lymphoma Treatment Drugs is very important in curing Lymphoma illness.

  • Lymphoma
  • Pharmaceutical
  • China
  • Beijing Wintic Pharma Co., Ltd
  • Pfizer Inc.

Lymphoma Treatment Drugs Industry Forecasts - China Focus

  • $ 1800
  • October 2019
  • 84 pages

LYMPHOMA TREATMENT DRUGS PRODUCTION AND I.

  • Pharmaceutical
  • China
  • Demand
  • Trade
  • Jiangsu HengRui Medicine Co., Ltd.

Market Spotlight: Gastrointestinal Stromal Tumor (GIST), Pharma Intelligence

  • $ 1318
  • April 2020
  • 43 pages

lymphoma, and proportion of individuals with TLS, 2017 ## Table ##: Incident cases of TLS in Burkitt’s lymphoma, 2017–## ## Table ##: Marketed drugs for TLS ## Table ##: Parent patents in TLS ## Table ##: Historical global sales, by drug ($m), 2014–## ## Table ##: Forecasted global sa

  • Clinical Trial
  • Drug Development
  • Lymphoma
  • China
  • World

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2020

  • $ 3495
  • April 2020
  • 400 pages

Lymphoma Society, LifeLink Foundation, LifeLiver, LifeQ, LineaRx, Lipidor, LogicNets, Loreal, Louisiana State University, Loxo Oncology, Lupin Limited, Luye Pharma Group, Macrogen, MAKScientific, Mallinckrodt Pharmaceuticals, Marina Biotech, Marshall Institute for Interdisciplinary Research

  • Biotechnology
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • China

Hodgkin’s Lymphoma - Opportunity Analysis and Forecasts to 2029

  • $ 10995
  • June 2020
  • 140 pages

M. (2019) CANCER, LYMPHOMA, HODGKIN, STATPEARLS.

  • Cancer
  • Chemotherapy
  • Lymphoma
  • Therapy
  • China

Prostate Cancer: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • August 2019
  • 212 pages

BAY-##, AN ORAL ATR INHIBITOR, IS BEING INVESTIGATED IN A PHASE I STUDY (BAYER, NCT##) IN SOLID TUMORS (INCLUDING PCA) AND LYMPHOMAS.

  • Hospital
  • Lymphoma
  • Prostate Cancer
  • Therapy
  • China

T-Cell Immunotherapy Market (3rd Edition), 2018-2030

  • $ 3499
  • April 2018
  • 850 pages

LEUKEMIA AND LYMPHOMA ##. ##. ##. ##.

  • Immunotherapy
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • China

China Oral Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2025

  • $ 2000
  • February 2020
  • 40 pages

Lymphomas ##.

  • Cancer
  • Lymphoma
  • Oropharynx Cancer
  • China
  • Market Size

Multiple Myeloma: Global Drug Forecast and Market Analysis to 2027

  • $ 10995
  • March 2019
  • 164 pages

THE LEUKEMIA AND LYMPHOMA SOCIETY (2015) MYELOMA.

  • Cancer
  • Cancer Hormonal Therapy
  • Lymphoma
  • Therapy
  • China

Colorectal Cancer: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • April 2020
  • 153 pages

FRANCE AND GERMANY ITALY SPAIN TO DETERMINE THE DISTRIBUTION OF DIAGNOSED INCIDENT CASES OF CRC BY STAGE AT DIAGNOSIS IN SPAIN, A RETROSPECTIVE FOLLOW-UP STUDY OF INDIVIDUALS DIAGNOSED WITH CRC (EXCLUDING CASES WITH DEATH CERTIFICATE-ONLY INFORMATION AND LYMPHOMAS) DURING 2006-2011 WAS USED

  • Colorectal Cancer
  • Lymphoma
  • Targeted Therapy
  • Therapy
  • China

Brain Cancer: Epidemiology Forecast to 2027

  • $ 3995
  • October 2018
  • 32 pages

Brain Cancer: Epidemiology Forecast to 2027 Summary Epidemiologists forecast that the diagnosed incident cases of brain cancer will increase from 119,717 cases in 2017 to 151,067 cases in 2027, at an ...

  • Brain Cancer
  • Cancer
  • Lymphoma
  • Pathology
  • China

CAR-T Therapies Market, 2018-2030

  • $ 3499
  • July 2018
  • 550 pages

Leukemia and Lymphoma ##. ##. ##. ##.

  • Lymphoma
  • Medical Biotechnology
  • Therapy
  • China
  • United States

Age-Related Macular Degeneration: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • April 2020
  • 204 pages

Age-Related Macular Degeneration: Global Drug Forecast and Market Analysis to 2028 Summary Age-related macular degeneration (AMD) is an eye condition that is characterized by the gradual deterioration ...

  • Lymphoma
  • Ophthalmology
  • Targeted Therapy
  • Therapy
  • China

China Cancer Test Market, Volume, Forecast (By Male & Female), Mortality & 26 Cancer (Oncology) Types Market & Volume to 2022

  • $ 2200
  • August 2017
  • 357 pages

Lymphoma ##.

  • Cancer
  • Lymphoma
  • Pathology
  • China
  • East Asia

Hodgkin Lymphoma - Epidemiology Forecast to 2029

  • $ 3995
  • June 2020
  • 44 pages

LYMPHOMA WAS DEFINED BY THE ICD-## CODES C##-C##, C##, C##, AND C##.

  • Cancer
  • Hospital
  • Lymphoma
  • China
  • Forecast

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • August 2019
  • 228 pages

So the CAR T, for example, represents a cure of lymphoma and leukemia.

  • Blood Disease
  • Lymphoma
  • Pathology
  • Therapy
  • China

The Chinese Pharmaceutical Market to 2030

  • $ 3000
  • March 2020
  • 101 pages

-Increase your foothold in the Chinese market TODAY -Establish partnerships to manufacture, distribute or develop Chinese products -Scope out the market prior to entry   This new report covers the ...

  • Pharmaceutical
  • China
  • East Asia
  • Fosun International Limited
  • Pfizer China

Bladder Cancer Treatment Drugs Industry Forecasts - China Focus

  • $ 1800
  • May 2020
  • 120 pages

Epirubicin is primarily used against breast and ovarian cancer, gastric cancer, lung cancer, and lymphomas.

  • Bladder Cancer
  • Lymphoma
  • Therapy
  • Vaccine
  • China

Skin Cancer Treatment Drugs Industry Forecasts - China Focus

  • $ 1800
  • June 2020
  • 103 pages

It is also being studied for use against some leukemia, lymphomas, and other cancers, as well as some other diseases.

  • Lymphoma
  • Skin Cancer
  • Therapy
  • China
  • Demand
View report >

Therapy Market in China

  • March 2018
  • 39 pages

According to research article " Distribution pattern of lymphoma subtypes in China: A nationwide multicenter study of ##, ## cases", DLBCL accounts for c. ##% of total lymphoma cases, while FL represents c. ##% of all lymphoma cases.

  • Lymphoma
  • Therapy
  • China
  • Sino Biopharmaceutical Limited
  • SWS Research Co., Ltd.

Gasoline Market October 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on